11/22
07:56 am
bolt
Bolt Biotherapeutics (NASDAQ:BOLT) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
Bolt Biotherapeutics (NASDAQ:BOLT) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
11/12
04:53 pm
bolt
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
11/12
04:05 pm
bolt
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
Low
Report
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update